{"nct_id":"NCT05374512","title":"A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2022-05-16","start_date_type":"ACTUAL","primary_completion_date":"2025-12-03","primary_completion_date_type":"ESTIMATED","completion_date":"2025-12-03","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}